Category: Corona Virus

Page 349«..1020..348349350351..360370..»

New COVID variant is still really unpredictable, experts say. Heres why – Deseret News

April 5, 2022

By now, theres a good chance youve heard about the BA.2 variant of the coronavirus but experts are unsure about what to make of it.

Driving the news: Experts recently told The Daily Beast that the new BA.2 COVID-19 variant has been confusing because it has dominated some countries while remaining mostly absent from other parts of the world.

The bigger picture: COVID-19 cases are still spreading across the world. China has had to contend with new coronavirus subtypes including new mutations of the omicron variant, per Bloomberg as the United Kingdom has had to battle omicron XE, a hybrid version of two omicron variant mutations.

Excerpt from:

New COVID variant is still really unpredictable, experts say. Heres why - Deseret News

212 more coronavirus cases have been reported across Maine – observer-me.com

April 3, 2022

By Leela Stockley, Bangor Daily News StaffAnother 256 coronavirus cases have been reported across the state, Maine health officials said Saturday.Saturdays report brings the total number of coronavirus cases in Maine to 236,258, according to the Maine Center for Disease Control and Prevention.

By Leela Stockley, Bangor Daily News Staff

Another 256 coronavirus cases have been reported across the state, Maine health officials said Saturday.

Saturdays report brings the total number of coronavirus cases in Maine to 236,258, according to the Maine Center for Disease Control and Prevention. Thats up from 236,046 on Friday.

Of those, 171,079 have been confirmed positive, while 65,179 were classified as probable cases, the Maine CDC reported.

No new deaths were reported on Saturday, leaving the statewide death toll at 2,202.

The number of coronavirus cases diagnosed in the past 14 days statewide is 2,562. This is an estimation of the current number of active cases in the state, as the Maine CDC is no longer tracking recoveries for all patients. Thats up from 2,509 on Friday.

The new case rate statewide Saturday was 1.58 cases per 10,000 residents, and the total case rate statewide was 1,765.22.

The most cases have been detected in Mainers younger than 20, while Mainers over 80 years old account for the largest portion of deaths. More cases have been recorded in women and more deaths in men.

So far, 4,568 Mainers have been hospitalized at some point with COVID-19, the illness caused by the new coronavirus.

Of those, 91 are currently hospitalized, with 17 in critical care and five on a ventilator. Overall, 86 out of 349 critical care beds and 259 out of 329 ventilators are available.

The total statewide hospitalization rate on Saturday was 34.13 patients per 10,000 residents.

Cases have been reported in Androscoggin (22,404), Aroostook (12,711), Cumberland (48,183), Franklin (5,664), Hancock (7,358), Kennebec (22,882), Knox (5,917), Lincoln (5,164), Oxford (11,242), Penobscot (27,367), Piscataquis (2,967), Sagadahoc (5,064), Somerset (9,593), Waldo (6,012), Washington (4,332) and York (39,387) counties. Information about where an additional 11 cases were reported wasnt immediately available.

An additional 2,291 vaccine doses were administered in the previous 24 hours. As of Saturday, 1,001,610 Mainers are fully vaccinated, or about 78.21 percent of eligible Mainers, according to the Maine CDC.

As of Saturday morning, the coronavirus had sickened 80,140,311 people in all 50 states, the District of Columbia, Puerto Rico, Guam, the Northern Mariana Islands and the U.S. Virgin Islands, as well as caused 982,374 deaths, according to the Johns Hopkins University of Medicine.

Go here to read the rest:

212 more coronavirus cases have been reported across Maine - observer-me.com

CDC confirms risk of heart issues after COVID-19 infection, 2nd vax dose – WJW FOX 8 News Cleveland

April 3, 2022

TAMPA, Fla. (WFLA) For the millions of Americans that have gotten COVID-19, the health care journey isnt over. The U.S. Centers for Disease Control and Prevention confirmed in a new report that the risk of cardiac complications persists following infection and recovery.

The report released April 1 paints the picture of ongoing risks and negative health outcomes that could spring up after a patient has gotten COVID-19. The report also touches on the potential risk of heart issues after receiving an mRNA vaccine for the coronavirus. The two mRNA vaccines available are from Pfizer and Moderna.

The report said cardiac complications, particularly myocarditis and pericarditis, have been tied to COVID-19 infection and mRNA COVID-19 vaccination. Additionally, the study by the CDC found cases of multisystem inflammatory syndrome, which the health agency described as a rare but serious complication of SARS-CoV-2 infection with frequent cardiac involvement.

The study found the risk for all three cardiac conditions was increased between one and three weeks after infection or vaccination.

Male youths were the patient group with the highest level of risk for developing the cardiac conditions after both vaccination and infection. For male patients 12 to 17 years old, the CDC said the risk for cardiac outcomes was highest after the second vaccine dose from an mRNA vaccine, but was even higher after a COVID-19 infection.

The incidence of cardiac outcomes after mRNA COVID-19 vaccination was highest for males aged 1217 years after the second vaccine dose; however, within this demographic group, the risk for cardiac outcomes was 1.85.6 times as high after SARS-CoV-2 infection than after the second vaccine dose, the CDC said. The risk for cardiac outcomes was likewise significantly higher after SARS-CoV-2 infection than after first, second, or unspecified dose of mRNA COVID-19 vaccination for all other groups by sex and age.

However, the CDC study specifically focuses on risks from mRNA vaccines, meaning the Johnson & Johnson shot is not included in the treatments and prevention options that may provide additional risks to patients.

The CDC said due to their findings, they continue to support use of the mRNA vaccines for COVID-19 among all eligible patients, which is anyone 5 years or older.

The study data used was pulled from 40 health care systems to study the risk of cardiac complications from COVID-19 and mRNA vaccinations for COVID-19, among male and female patients across multiple age demographics.

Read more from the original source:

CDC confirms risk of heart issues after COVID-19 infection, 2nd vax dose - WJW FOX 8 News Cleveland

New Fishers COVID testing and vaccination site opens Monday – WISH TV Indianapolis, IN

April 3, 2022

FISHERS, Ind. (WISH) A new coronavirus testing and vaccination site opens Monday in Fishers.

The Fishers Health Department will only offer testing and vaccines at the Fishers Health Department Clinic at 8937 Technology Drive.

The health department previously closed two other testing and vaccination sites and says it is consolidating all services into one location due to declining infection rates, declining demand for testing, and the citys outstanding COVID-19 rates.

Free drive-thru COVID-19 rapid tests are available by appointment only for people ages five and up.

COVID-19 tests will be available during the following times:

For COVID-19 vaccines, people can walk-in or schedule appointments ahead of time for first, second, and booster vaccinations.

The Fishers Health Departments non-COVID-19 testing site will be open in the same location. It offers vaccinations for flu, HPV, meningitis, and more. Immunizations are by appointment only and can be scheduled online. Vaccines are available from 1 p.m. to 4 p.m. on Tuesdays and 9 a.m. to noon on Fridays.

More here:

New Fishers COVID testing and vaccination site opens Monday - WISH TV Indianapolis, IN

‘Stealth omicron’ on the rise in North Dakota, but COVID-19 cases remain low – Bismarck Tribune

April 2, 2022

The BA.2 omicron subvariant of the coronavirus is beginning to assert itself in North Dakota, and health officials are on guard.

The subvariant that's known to be even more infectious than the original omicron has caused new outbreaks in Europe and Asia and is now the dominant cause of COVID-19 in the U.S.,accounting for more than half of recent cases that have undergone the"sequencing" process through which variants are determined,according to the U.S. Centers for Disease Control and Prevention.

The so-called "stealth omicron" hasn't reached that level yet in North Dakota -- accounting for only about 5% of all specimens recently sequenced -- but confirmed cases are on the rise, according toKirby Kruger, head of the Health Department's disease control division and forensic pathology section.The coronavirus and its variants and subvariants have been slower to arrive in North Dakota than in some other parts of the country throughout the pandemic.

People are also reading

About 5-10% of total positive COVID-19 tests weekly in North Dakota typically undergo the sequencing process, enough to give state health officials a sufficient sample size. State data shows 45 confirmed BA.2 cases, up eight from last week. At the beginning of the month, there were 14 cases.

"When looking only at the most recent specimens to be sequenced by our lab, we are starting to see a greater percentage of BA.2," Kruger said. "Of the specimens collected on or after March 20 and determined to be omicron, 27.5% were BA.2. So we are starting to see a greater proportion of BA.2."

Other known variants in North Dakota besides omicron are alpha, beta, gamma, delta, epsilon and mu, though there have been no cases of any but delta for months.

Scientists say one reason the BA.2 subvariant has gained ground is that its about 30% more contagious than the original omicron, according to The Associated Press. But it doesnt seem to cause more severe disease than the original, and vaccines appear just as effective against it. Unvaccinated people are at far greater risk.

"Because it is more infectious, we are watching to see if this subvariant may drive another increase in cases here," Kruger said.

"One additional monoclonal antibody has been found to be ineffective against the BA.2 subvariant," he added. "Vaccination and booster doses remain our best tool to prevent serious illness and hospitalizations."

Federal datashows that North Dakotacontinues to have some of the worst COVID-19 vaccination rates in the country: 65.3% of adults in the state are fully vaccinated, with the rate for all vaccine-eligible people -- age 5 and older -- at 58.8%.Neither rate increased over the week.The national averages are 75.5% and 69.7%, respectively.

COVID-19 booster shots are recommended for people 12 and older. North Dakota's booster rate is 41.7%, compared to 46.6% nationally.The state rate is unchanged from last week.

The U.S. Food and Drug Administration this week authorized second booster doses of Pfizer or Moderna COVID-19 vaccine for people age 50 and older, and for those age 12 and older with weakened immune systems. The CDC endorsed the additional booster. North Dakota's Health Department is urging eligible people to consider it.

Real-world data from Israel shows that an additional booster dose is safe and life-saving," state Immunization Director Molly Howellsaid. "Mortality due to the omicron variant in this data set was significantly lower -- a 78% reduction -- in those ages 60 and older in Israel who received an additional booster dose.

Molly Howell, the North Dakota Department of Health's immunization program manager

Weekly data

BA.2 isn't pushing COVID-19 cases up yet in North Dakota.

The Health Department's now-weekly coronavirus dashboard shows 193 new cases over the past week, compared with the previous three weekly totals of 242, 336 and 555 new cases, respectively.

The dashboard posted Friday showed that coronavirus patients made up just 2.5% of occupied inpatient beds statewide and about 6% of ICU beds. There were 19 COVID-19 admissions during the week, down from 32 the previous week and 56 the week before that.The two hospitals in Bismarck as of Thursday had atotalof six staffed inpatient hospital beds available and five intensive care unit beds open.

There have been 239,861 confirmed COVID-19 cases in North Dakota during the pandemic that began in March 2020. Data posted by the CDC shows 2,245 virus-related deaths, 13 more than last week. County-level death data is not available.

The state no longer reports the number of active COVID-19 cases, as part of its recent shift from daily public reporting to weekly reporting.

The data reported to the public now emphasizes trends over time and severity of disease, rather than daily case counts and test positivity rate -- data that state health officials say could be skewed by the fact that results from widely available COVID-19 home test kits are not required to be reported to the state.

More information

County-level COVID-19 risks determined by theCDC can be found athttps://bit.ly/3Clifrq. Burleigh and Morton counties both are considered at low risk, as is most of the state.

State Health Department guidance and resources for businesses is athttps://bit.ly/3w0DpKj.

Go tohttps://www.ndvax.orgor call 866-207-2880 to see where COVID-19 vaccine is available. Information on free public testing and free test kits is athealth.nd.gov/covidtesting. More detailed pandemic information is atwww.health.nd.gov/coronavirusandhttps://www.cdc.gov/coronavirus/2019-ncov/index.html.

Reach News Editor Blake Nicholson at 701-250-8266 or blake.nicholson@bismarcktribune.com.

Sign up now to get the most recent coronavirus headlines and other important local and national news sent to your email inbox daily.

Read more here:

'Stealth omicron' on the rise in North Dakota, but COVID-19 cases remain low - Bismarck Tribune

Printable zine: When and how to dial down your COVID precautions : Goats and Soda – NPR

April 2, 2022

We regularly answer frequently asked questions about life during the coronavirus crisis. If you have a question you'd like us to consider for a future post, email us at goatsandsoda@npr.org with the subject line: "Weekly Coronavirus Questions." See an archive of our FAQs here.

I live in a place where case counts are dropping. I know they could go back up again, but in the meantime, what COVID precautions are advisable (if any) and what precautions can be put on hold?

First things first: The pandemic isn't over. The current surge in Hong Kong, for instance, has produced the highest reported death rate over the past two-plus years of COVID. And the U.S. still has 700 COVID deaths a day far fewer than a couple of weeks ago but still a staggering and tragic count.

And the highly transmissible variant omicron BA.2 that's causing surges in some countries is now the dominant variant in the U.S. and could bring a surge.

But for the vaccinated and boosted in places where numbers are trending downward, times have changed at least for the moment. Mandatory and even voluntary mask-wearing is on the wane. (If you don't believe me, come to my neighborhood coffee shop where half the servers and customers are masked and half aren't.)

If you're fortunate enough to live and work in a community where numbers are dropping, it is indeed an appropriate moment to assess your own risks and the risks of those in your inner circle. And then perhaps adjust your personal precautions.

As Dr. Preeti Malani puts it, you might decide to "dial it down" precaution-wise but also be prepared to "dial it up" if things change. She's an infectious disease doctor and the chief health officer at the University of Michigan.

So what is a low case count? The Centers for Disease Control and Prevention as well as local health departments will provide numbers for your community. Those numbers are probably undercounts because not everyone reports a self-diagnosed case of COVID. And current numbers may reflect more the reality of a few days before than the present moment. But in general, COVID specialists we surveyed say 10 daily cases or fewer per 100,000 population is pretty darned low.

For example, if you've only been an outdoor diner at restaurants, you might weigh going indoors, Malani says keeping in mind that there are ways to minimize any potential COVID exposure.

"Maybe go when it's not super-crowded, sit in the corner where fewer people are crowded up against you or at a table where you're not that close to other people, wear a mask when you're not eating," she suggests. She also recommends picking a restaurant with good ventilation "it matters a lot" in terms of disrupting the flow of exhaled pathogens. "I'm thinking of restaurants with high ceilings and open windows, not a cramped basement."

You also might avoid indoor settings where people are shouting a lot, she notes. "Tonight my Wolverines are playing against Villanova. I'm gonna watch it with some friends at home, not in a crowded bar."

The decision to ease up (or not) is highly personal. That's a key point made by the three experts we interviewed.

Some people are sticking with their pandemic precautions because they are at high risk of severe disease or have regular contact with others in that category. This would include the over-60 set, the immunocompromised, people who regularly see an elderly relative or babies (who are more vulnerable than toddlers).

And it's hard to give up habits that are two years old, notes Dr. Jill Weatherhead, assistant professor of adult and pediatric infectious diseases at Baylor College of Medicine. COVID-19 precautions are "engrained in your daily behaviors," she says. "Lifting mitigation strategies now can be especially difficult for those who work in health-care settings, have lost individuals to COVID-19 or are high-risk of severe disease."

Yet it's also nice to re-embrace old routines. Infectious disease doctor Abraar Karan is back in the gym and going at times when the place isn't packed and wearing a mask. When he took his mask off for a drink of water one day, he was struck by the ... er ... aroma of gyms. Which, as you may recall, is not exactly lilacs and roses. "When I was in the gym and took my mask off to drink water, I forgot how bad it stinks," he says. So that's an added benefit to wearing a mask in a place where people may be breathing heavily (and sweating as well).

Of course there will inevitably be times when you're just not sure what to do. Say you're back at work and masked and get invited to a meeting in a small room where you're uncertain about the air circulation and where people are masked but with a variety of masks, from the less effective cloth variety to the highly effective N95/KN95.

Feeling uneasy? Karan notes that in the hospital where he works, "we have meetings like this all the time. Everyone is wearing surgical masks. And we have not had any outbreaks." Why the blue surgical masks and not the more effective N95s? Those masks were used during meetings in January and February when there were a lot of cases, he says, and there was more concern about possible transmission in staff meetings. That's not the case at this point in time. Also, surgical masks are less expensive.

And of course "you can use a higher grade mask if you have personal concerns," he says.

Another point to keep in mind: "We've forgotten that distance also makes a difference" in terms of risks of infection, says Malani. Staying six feet or so from others will reduce your risk of infection. So it's okay to avoid the main table at a meeting room or even ask to use a Zoom option if that's possible to reduce chances of infection.

As people assess their degree of caution, they'll also likely weigh what's happening in their life. Going on a trip or special outing? You might ramp up your protective measures say a week or so in advance so you don't come down with COVID that could result in a positive PCR test if you're flying out of the country or just put your outing on hold. That kind of pre-trip mindset can also be helpful in avoiding the fate of two of my acquaintances, who traveled out of the country and soon learned they had COVID and had to isolate in their hotel rooms for days.

Expecting a visitor who's flying in from a surge area? Have them mask up for 3 to 5 days and then take a COVID test. "That gives you a little extra assurance," says Malani.

The other thing that humanity has to keep in mind is that we all have to respect each other's choices. "The big message is that at this point [if you live in an area] with levels low, everyone has to evaluate their own risk, their own family's risk," says Weatherhead. And those decisions, she stresses, "should be respected" by all.

More:

Printable zine: When and how to dial down your COVID precautions : Goats and Soda - NPR

Covid vaccines give extra protection to previously infected, studies show – The Guardian

April 2, 2022

Covid-19 vaccines provide significant extra protection for people who have already been infected, according to two new studies.

The jabs have proven highly effective in protecting those who have never had Covid, but their effectiveness at preventing symptoms and severe outcomes in people who have previously been infected has, until recently, been less clear.

Now two separate pieces of research, published in the Lancet Infectious Diseases journal, confirm that Covid-19 vaccines provide additional protection for people who have already been infected with Sars-CoV-2 especially against severe disease.

In the first study, conducted in Brazil, researchers found that four vaccines CoronaVac, Oxford/AstraZeneca, Janssen and Pfizer/BioNTech provide extra protection against symptomatic reinfection and severe outcomes such as hospitalisation and death in people who had previously caught coronavirus.

The second study, from Sweden, found that vaccination against Covid-19 provided additional protection to those who had had Covid before, for at least nine months.

Together, the studies provide crucial data on vaccine effectiveness in people with a prior infection and underline the benefits of getting vaccinated regardless of whether someone has had Covid. Experts say the findings could also help inform global vaccine strategies.

Covid-19 vaccines have been proven to be highly effective at preventing symptomatic infection and hospitalisation among those with no prior infection but effectiveness for those with prior infection is less clear, said the author of the first study, Julio Croda, of Universidade Federal de Mato Grosso do Sul and Fundao.

Understanding the duration and effectiveness of immunity for those vaccinated with a previous Covid-19 diagnosis becomes increasingly important as the pandemic progresses and surges new cases may occur as a result of more transmissible variants. Further research on the need for vaccination for those with a previous Covid-19 infection is a vital step to pandemic policy intervention including guidance on single dose or two dose vaccine protection.

In the first study, which involved more than 22,000 people who became reinfected with Covid, the data showed that being vaccinated reduced their risk of symptoms, being hospitalised or dying.

All four of these vaccines have proven to provide significant extra protection for those with a previous Covid-19 infection, reducing hospitalisation and death, said Croda. There has been ongoing public debate about whether previously infected individuals need to be vaccinated. Our results suggest that vaccine benefits far outweigh any potential risk and support the case for vaccination, including the full vaccine series, among individuals with prior Sars-CoV-2 infection.

Writing in the same journal, Pramod Kumar Garg, of the Translational Health Science and Technology Institute, India, who was not involved in the study, said: The results of [the Brazil] study and other recent studies challenge the concept of population-level herd immunity through natural infection alone against Sars-CoV-2 and suggest that vaccinating individuals who were previously infected provides further protection, particularly against severe disease. These data should help guide policy decisions and mitigate vaccine hesitancy among people who had Sars-CoV-2 infection.

The second study, involving almost 3 million people, found that one vaccine dose in someone with infection-driven immunity from a previous infection lowered their risk of reinfection by 58% two months after the jab. Two doses of vaccine lowered the risk of infection by 66%.

The authors acknowledged limitations with both studies, including a risk of bias due to the observational nature of the research. Additionally, neither study included an analysis of reinfection from the Omicron variants.

Writing in the same journal, Jennifer Juno, of the University of Melbourne, Australia, who was not involved in either study, said: These data confirm, in a large cohort, the added protective benefit of vaccination among individuals recovered from Covid-19.

Originally posted here:

Covid vaccines give extra protection to previously infected, studies show - The Guardian

CDC confirms risk of heart issues after COVID-19 infection, 2nd vax dose – WFLA

April 2, 2022

TAMPA, Fla. (WFLA) For the millions of Americans that have gotten COVID-19, the health care journey isnt over. The U.S. Centers for Disease Control and Prevention confirmed in a new report that the risk of cardiac complications persists following infection and recovery.

The report released April 1 paints the picture of ongoing risks and negative health outcomes that could spring up after a patient has gotten COVID-19. The report also touches on the potential risk of heart issues after receiving an mRNA vaccine for the coronavirus. The two mRNA vaccines available are from Pfizer and Moderna.

The report said cardiac complications, particularly myocarditis and pericarditis, have been tied to COVID-19 infection and mRNA COVID-19 vaccination. Additionally, the study by the CDC found cases of multisystem inflammatory syndrome, which the health agency described as a rare but serious complication of SARS-CoV-2 infection with frequent cardiac involvement.

The study found the risk for all three cardiac conditions was increased between one and three weeks after infection or vaccination.

In some respects, the CDC report provides support to a stance taken weeks ago by the DeSantis administration and Florida Department of Health specifically, the updated guidance provided by State Surgeon General Dr. Joseph Ladapo which recommended against healthy children receiving COVID-19 vaccines.

Male youths were the patient group with the highest level of risk for developing the cardiac conditions after both vaccination and infection. For male patients 12 to 17 years old, the CDC said the risk for cardiac outcomes was highest after the second vaccine dose from an mRNA vaccine, but was even higher after a COVID-19 infection.

The incidence of cardiac outcomes after mRNA COVID-19 vaccination was highest for males aged 1217 years after the second vaccine dose; however, within this demographic group, the risk for cardiac outcomes was 1.85.6 times as high after SARS-CoV-2 infection than after the second vaccine dose, the CDC said. The risk for cardiac outcomes was likewise significantly higher after SARS-CoV-2 infection than after first, second, or unspecified dose of mRNA COVID-19 vaccination for all other groups by sex and age.

However, the CDC study specifically focuses on risks from mRNA vaccines, meaning the Johnson & Johnson shot is not included in the treatments and prevention options that may provide additional risks to patients.

The CDC said due to their findings, they continue to support use of the mRNA vaccines for COVID-19 among all eligible patients, being anyone 5 years or older.

In an updated FDOH guidance released on March 8, the state health department included the following risks for vaccination, when recommending against receiving the shots:

The FDOH cited studies to support their recommendation.

At the time, the CDC remained supportive of vaccination, and the U.S. Food and Drug Administration said the vaccines had continued to prove safe and effective.

The new CDC study still supports use of COVID-19 vaccinations, though it found the risks were higher among young, biologically male patients, rather than all patients between 12 and 17 years old.

The study data used was pulled from 40 health care systems to study the risk of cardiac complications from COVID-19 and mRNA vaccinations for COVID-19, among male and female patients across multiple age demographics.

Go here to read the rest:

CDC confirms risk of heart issues after COVID-19 infection, 2nd vax dose - WFLA

Regional health officials wrapping up coronavirus response | Serving Minden-Gardnerville and Carson Valley – The Record-Courier

April 2, 2022

A National Guardsman conducts helps conduct community coronavirus testing at East Fork Station 12 in Sunridge on Dec. 8, 2020. Official said 440 people were tested during the event.Photo by Kurt Hildebrand.

Today marks the last day Douglas residents may call the Quad-County COVID-19 hotline.

While information will still be posted to gethealthycarsoncity.org, the hotline at (775) 283-4789 has been open since at least March 12, 2020, when the first case of coronavirus was reported by Carson City Health and Human Services.

Five days after the first case in Carson City was announced, Nevada was ordered into a statewide lockdown.

Friday also marked two years to the day that it was announced that the Nevada National Guard would aid in the states response to the coronavirus.

Guard members served at testing events across the four counties, providing assistance to regional health authorities.

The Guards mission officially wraps up today. At the peak of the Guards involvement in April 2020, there were 1,139 members assisting the state, the largest domestic emergency response in its history. With Guard members on orders for more than 700 days, it was also the longest deployment in state history.

A total of 1,400 Nevada Guard members directly administered 821,227 coronavirus tests and 818,661 vaccinations across the state.

They also conducted traffic control and wrangled paperwork for the testing and vaccination clinics.

Vaccination clinics are expected to continue through April, though after that residents will have to obtain vaccinations through pharmacies.

Carson City Health and Human Services will conduct clinics 2:30-4 p.m. April 14 and April 28 at the Douglas County Community & Senior Center, 1329 Waterloo Lane, Gardnerville.

While the Pfizer and Moderna vaccines will be available, Janssen vaccines will stop being offered on April 11.

According to the Nevada Health Response homepage, Douglas County was seeing one new daily confirmed case of the virus after a total of 6,597 cases over the last two years. That figure is likely to be low, as residents self-testing isnt reported to the state.

Douglas County Emergency Management reported distributing 9,000 free self-test kits in the state.

No new hospitalizations have been reported and 91 deaths have been attributed to the virus since the first in August 2020. Nine of those deaths have occurred since Feb. 7, according to Nevada Health Response.

Read the original post:

Regional health officials wrapping up coronavirus response | Serving Minden-Gardnerville and Carson Valley - The Record-Courier

Page 349«..1020..348349350351..360370..»